Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic Manufacturing - Barron's
1. LLY plans to manufacture its weight-loss pill in the U.S. 2. New drug, orforglipron, cleared late-stage trials with significant efficacy results. 3. LLY stock surged over 14% after promising trial results. 4. Company could avoid import taxes by producing in the U.S. 5. Trump suggests potential pharma tariffs impacting the industry.